Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,619	10,654	8,050	-	-	-
Market Cap Growth	1.68%	32.35%	-	-	-	-
Enterprise Value	10,453	10,534	7,954	-	-	-
Last Close Price	151.70	149.08	110.34	-	-	-
PE Ratio	23.74	29.88	27.53	-	-	-
Forward PE	21.34	25.61	25.41	-	-	-
PS Ratio	7.29	8.08	7.31	-	-	-
PB Ratio	6.43	7.15	5.73	-	-	-
P/TBV Ratio	6.49	7.20	5.79	-	-	-
P/FCF Ratio	34.07	51.60	32.10	-	-	-
P/OCF Ratio	29.61	40.46	27.20	-	-	-
PEG Ratio	1.52	1.60	1.01	-	-	-
EV/Sales Ratio	7.18	7.99	7.23	-	-	-
EV/EBITDA Ratio	19.98	24.82	23.28	-	-	-
EV/EBIT Ratio	21.72	27.16	25.19	-	-	-
EV/FCF Ratio	33.54	51.02	31.72	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.01	0.00	0.01	0.01	0.01	0.34
Debt / FCF Ratio	0.01	0.01	0.01	0.02	0.02	0.86
Asset Turnover	0.75	0.77	0.72	0.65	0.50	0.58
Inventory Turnover	2.13	1.98	2.18	2.44	1.97	2.99
Quick Ratio	3.13	3.65	3.58	4.16	3.90	2.90
Current Ratio	4.18	5.10	5.04	5.42	5.06	3.54
Return on Equity (ROE)	28.89%	24.63%	22.32%	14.00%	14.16%	18.40%
Return on Assets (ROA)	14.86%	14.15%	12.89%	10.67%	7.93%	10.79%
Return on Capital (ROIC)	18.70%	16.72%	15.04%	12.36%	9.25%	12.59%
Return on Capital Employed (ROCE)	26.60%	24.70%	21.40%	18.90%	14.40%	19.10%
Earnings Yield	4.21%	3.35%	3.63%	-	-	-
FCF Yield	2.93%	1.94%	3.12%	-	-	-
Dividend Yield	2.02%	2.05%	2.27%	-	-	-
Payout Ratio	54.14%	60.87%	23.94%	86.85%	66.40%	43.83%
Buyback Yield / Dilution	-	-	-	-600.00%	-	-
Total Shareholder Return	2.02%	2.05%	2.27%	-600.00%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.